<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Tumor-infiltrating lymphocytes - Wikipedia</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":false,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"8664957a-1c36-48aa-8d74-47867a4a97da","wgCSPNonce":false,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Tumor-infiltrating_lymphocytes","wgTitle":"Tumor-infiltrating lymphocytes","wgCurRevisionId":1060517838,"wgRevisionId":1060517838,"wgArticleId":14580464,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Lymphocytes","Oncology"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Tumor-infiltrating_lymphocytes","wgRelevantArticleId":14580464,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[]
,"wgRestrictionMove":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFDisplayWikibaseDescriptions":{"search":true,"nearby":true,"watchlist":true,"tagline":false},"wgWMESchemaEditAttemptStepOversample":false,"wgWMEPageLength":20000,"wgNoticeProject":"wikipedia","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsFlags":10,"wgULSCurrentAutonym":"English","wgEditSubmitButtonLabelPublish":true,"wgCentralAuthMobileDomain":false,"wgULSPosition":"interlanguage","wgULSisCompactLinksEnabled":true,"wgWikibaseItemId":"Q7852668","wgGENewcomerTasksGuidanceEnabled":true,"wgGEAskQuestionEnabled":false,"wgGELinkRecommendationsFrontendEnabled":false};RLSTATE={"ext.globalCssJs.user.styles":"ready","site.styles":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.vector.styles.legacy":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready",
"ext.wikimediaBadges":"ready","ext.uls.interlanguage":"ready","wikibase.client.init":"ready"};RLPAGEMODULES=["ext.cite.ux-enhancements","site","mediawiki.page.ready","mediawiki.toc","skins.vector.legacy.js","ext.gadget.ReferenceTooltips","ext.gadget.charinsert","ext.gadget.extra-toolbar-buttons","ext.gadget.refToolbar","ext.gadget.switcher","mmv.head","mmv.bootstrap.autostart","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.cx.eventlogging.campaigns","ext.centralNotice.geoIP","ext.centralNotice.startUp","ext.centralauth.centralautologin","ext.popups","ext.uls.compactlinks","ext.uls.interface","ext.growthExperiments.SuggestedEditSession"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1i9g4",function($,jQuery,require,module){mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cskins.vector.styles.legacy%7Cwikibase.client.init&amp;only=styles&amp;skin=vector"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=vector"></script>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector"/>
<meta name="generator" content="MediaWiki 1.39.0-wmf.6"/>
<meta name="referrer" content="origin"/>
<meta name="referrer" content="origin-when-crossorigin"/>
<meta name="referrer" content="origin-when-cross-origin"/>
<meta name="format-detection" content="telephone=no"/>
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/0/04/Tumor_microenvironment.jpg"/>
<meta property="og:image:width" content="1200"/>
<meta property="og:image:height" content="694"/>
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/0/04/Tumor_microenvironment.jpg/800px-Tumor_microenvironment.jpg"/>
<meta property="og:image:width" content="800"/>
<meta property="og:image:height" content="463"/>
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/0/04/Tumor_microenvironment.jpg/640px-Tumor_microenvironment.jpg"/>
<meta property="og:image:width" content="640"/>
<meta property="og:image:height" content="370"/>
<meta property="og:title" content="Tumor-infiltrating lymphocytes - Wikipedia"/>
<meta property="og:type" content="website"/>
<link rel="preconnect" href="//upload.wikimedia.org"/>
<link rel="alternate" media="only screen and (max-width: 720px)" href="//en.m.wikipedia.org/wiki/Tumor-infiltrating_lymphocytes"/>
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;action=edit"/>
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"/>
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"/>
<link rel="license" href="https://creativecommons.org/licenses/by-sa/3.0/"/>
<link rel="canonical" href="https://en.wikipedia.org/wiki/Tumor-infiltrating_lymphocytes"/>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<link rel="dns-prefetch" href="//login.wikimedia.org"/>
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Tumor-infiltrating_lymphocytes rootpage-Tumor-infiltrating_lymphocytes skin-vector action-view skin-vector-legacy"><div id="mw-page-base" class="noprint"></div>
<div id="mw-head-base" class="noprint"></div>
<div id="content" class="mw-body" role="main">
	<a id="top"></a>
	<div id="siteNotice"><!-- CentralNotice --></div>
	<div class="mw-indicators">
	</div>
	<h1 id="firstHeading" class="firstHeading mw-first-heading">Tumor-infiltrating lymphocytes</h1>
	<div id="bodyContent" class="vector-body">
		<div id="siteSub" class="noprint">From Wikipedia, the free encyclopedia</div>
		<div id="contentSub"></div>
		<div id="contentSub2"></div>
		
		<div id="jump-to-nav"></div>
		<a class="mw-jump-link" href="#mw-head">Jump to navigation</a>
		<a class="mw-jump-link" href="#searchInput">Jump to search</a>
		<div id="mw-content-text" class="mw-body-content mw-content-ltr" lang="en" dir="ltr"><div class="mw-parser-output"><div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Tumor_microenvironment.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/04/Tumor_microenvironment.jpg/220px-Tumor_microenvironment.jpg" decoding="async" width="220" height="127" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/04/Tumor_microenvironment.jpg/330px-Tumor_microenvironment.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/04/Tumor_microenvironment.jpg/440px-Tumor_microenvironment.jpg 2x" data-file-width="1156" data-file-height="669" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Tumor_microenvironment.jpg" class="internal" title="Enlarge"></a></div>During the elimination phase immune effector cells such as <a href="/wiki/Cytotoxic_T_cell" title="Cytotoxic T cell">CTL</a>’s and <a href="/wiki/NK_cells" class="mw-redirect" title="NK cells">NK cells</a> with the help of dendritic and <a href="/wiki/CD4" title="CD4">CD4+</a> T-cells are able to recognize and eliminate tumor cells.</div></div></div>
<p><b>Tumor-infiltrating lymphocytes</b> are <a href="/wiki/White_blood_cell" title="White blood cell">white blood cells</a> that have left the <a href="/wiki/Bloodstream" class="mw-redirect" title="Bloodstream">bloodstream</a> and <a href="/wiki/Cell_migration" title="Cell migration">migrated</a> towards a <a href="/wiki/Tumor" class="mw-redirect" title="Tumor">tumor</a>. They include <a href="/wiki/T_cells" class="mw-redirect" title="T cells">T cells</a> and <a href="/wiki/B_cells" class="mw-redirect" title="B cells">B cells</a> and are part of the larger category of ‘tumor-infiltrating immune cells’ which consist of both mononuclear and polymorphonuclear immune cells, (i.e., <a href="/wiki/T_cells" class="mw-redirect" title="T cells">T cells</a>, <a href="/wiki/B_cells" class="mw-redirect" title="B cells">B cells</a>, <a href="/wiki/Natural_killer_cells" class="mw-redirect" title="Natural killer cells">natural killer cells</a>, <a href="/wiki/Macrophages" class="mw-redirect" title="Macrophages">macrophages</a>, <a href="/wiki/Neutrophils" class="mw-redirect" title="Neutrophils">neutrophils</a>, <a href="/wiki/Dendritic_cells" class="mw-redirect" title="Dendritic cells">dendritic cells</a>, <a href="/wiki/Mast_cells" class="mw-redirect" title="Mast cells">mast cells</a>, <a href="/wiki/Eosinophils" class="mw-redirect" title="Eosinophils">eosinophils</a>, <a href="/wiki/Basophils" class="mw-redirect" title="Basophils">basophils</a>, etc.) in variable proportions. Their abundance varies with tumor type and stage and in some cases relates to disease prognosis <sup id="cite_ref-Teixeira2016_1-0" class="reference"><a href="#cite_note-Teixeira2016-1">&#91;1&#93;</a></sup><sup id="cite_ref-Hanahan2012_2-0" class="reference"><a href="#cite_note-Hanahan2012-2">&#91;2&#93;</a></sup><sup id="cite_ref-:1_3-0" class="reference"><a href="#cite_note-:1-3">&#91;3&#93;</a></sup><sup id="cite_ref-:2_4-0" class="reference"><a href="#cite_note-:2-4">&#91;4&#93;</a></sup><sup id="cite_ref-:3_5-0" class="reference"><a href="#cite_note-:3-5">&#91;5&#93;</a></sup>
</p><p>TILs can often be found in the tumor <a href="/wiki/Stroma_(animal_tissue)" class="mw-redirect" title="Stroma (animal tissue)">stroma</a> and within the tumor itself. Their functions can dynamically change throughout tumor progression and in response to anticancer therapy<sup id="cite_ref-Hanahan2012_2-1" class="reference"><a href="#cite_note-Hanahan2012-2">&#91;2&#93;</a></sup><sup id="cite_ref-:1_3-1" class="reference"><a href="#cite_note-:1-3">&#91;3&#93;</a></sup><sup id="cite_ref-:2_4-1" class="reference"><a href="#cite_note-:2-4">&#91;4&#93;</a></sup><sup id="cite_ref-:3_5-1" class="reference"><a href="#cite_note-:3-5">&#91;5&#93;</a></sup>
</p>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Tumour_infiltrating_lymphocytes_in_colorectal_carcinoma_-_very_high_mag.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/79/Tumour_infiltrating_lymphocytes_in_colorectal_carcinoma_-_very_high_mag.jpg/220px-Tumour_infiltrating_lymphocytes_in_colorectal_carcinoma_-_very_high_mag.jpg" decoding="async" width="220" height="147" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/79/Tumour_infiltrating_lymphocytes_in_colorectal_carcinoma_-_very_high_mag.jpg/330px-Tumour_infiltrating_lymphocytes_in_colorectal_carcinoma_-_very_high_mag.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/79/Tumour_infiltrating_lymphocytes_in_colorectal_carcinoma_-_very_high_mag.jpg/440px-Tumour_infiltrating_lymphocytes_in_colorectal_carcinoma_-_very_high_mag.jpg 2x" data-file-width="4272" data-file-height="2848" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Tumour_infiltrating_lymphocytes_in_colorectal_carcinoma_-_very_high_mag.jpg" class="internal" title="Enlarge"></a></div>Very high magnification <a href="/wiki/Micrograph" title="Micrograph">micrograph</a> of <b>tumor infiltrating lymphocytes</b>, abbreviated <b>TILs</b>, in a case of <a href="/wiki/Colorectal_cancer" title="Colorectal cancer">colorectal carcinoma</a>. TILs may also be spelled <i>tumour infiltrating lymphocytes</i>. <a href="/wiki/H%26E_stain" title="H&amp;E stain">H&amp;E stain</a>.</div></div></div>
<p>TILs are implicated in killing tumor cells. The presence of lymphocytes in tumors is often associated with better clinical outcomes (after surgery or immunotherapy).<sup id="cite_ref-Vanky1986_6-0" class="reference"><a href="#cite_note-Vanky1986-6">&#91;6&#93;</a></sup><sup id="cite_ref-Zhang2003_7-0" class="reference"><a href="#cite_note-Zhang2003-7">&#91;7&#93;</a></sup><sup id="cite_ref-Shaffer2016_8-0" class="reference"><a href="#cite_note-Shaffer2016-8">&#91;8&#93;</a></sup><sup id="cite_ref-:0_9-0" class="reference"><a href="#cite_note-:0-9">&#91;9&#93;</a></sup>
</p>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Detection_and_characteristics"><span class="tocnumber">1</span> <span class="toctext">Detection and characteristics</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Use_in_autologous_cell_therapy"><span class="tocnumber">2</span> <span class="toctext">Use in autologous cell therapy</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Use_in_adoptive_T_cell_transfer_therapy"><span class="tocnumber">3</span> <span class="toctext">Use in adoptive T cell transfer therapy</span></a>
<ul>
<li class="toclevel-2 tocsection-4"><a href="#History"><span class="tocnumber">3.1</span> <span class="toctext">History</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Process"><span class="tocnumber">3.2</span> <span class="toctext">Process</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#Clinical_Success"><span class="tocnumber">3.3</span> <span class="toctext">Clinical Success</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-7"><a href="#Associations_with_cancer_treatments"><span class="tocnumber">4</span> <span class="toctext">Associations with cancer treatments</span></a></li>
<li class="toclevel-1 tocsection-8"><a href="#See_also"><span class="tocnumber">5</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-9"><a href="#References"><span class="tocnumber">6</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-10"><a href="#External_links"><span class="tocnumber">7</span> <span class="toctext">External links</span></a></li>
</ul>
</div>

<h2><span class="mw-headline" id="Detection_and_characteristics">Detection and characteristics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;action=edit&amp;section=1" title="Edit section: Detection and characteristics">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>TILs can be found between the tumor cells, as TILs in the stroma surrounding the tumor cells do not count.<sup id="cite_ref-pmid19638537_10-0" class="reference"><a href="#cite_note-pmid19638537-10">&#91;10&#93;</a></sup>  TILs are often found floating around the tumor without actual penetration or action on the tumor cells. <a href="/wiki/Histologic" class="mw-redirect" title="Histologic">Histologic</a> definitions for TILs vary.
</p><p><a href="/wiki/CD3_(immunology)" title="CD3 (immunology)">CD3</a> has been used to detect lymphocytes in tumor samples.<sup id="cite_ref-Shaffer2016_8-1" class="reference"><a href="#cite_note-Shaffer2016-8">&#91;8&#93;</a></sup> Tumor immune infiltration can also be determined using gene expression methods like Microarray or RNA Sequencing through <a href="/wiki/Deconvolution" title="Deconvolution">deconvolution</a> methods such as <a href="/w/index.php?title=Cibersort&amp;action=edit&amp;redlink=1" class="new" title="Cibersort (page does not exist)">CIBERSORT</a>.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11">&#91;11&#93;</a></sup><sup id="cite_ref-:6_12-0" class="reference"><a href="#cite_note-:6-12">&#91;12&#93;</a></sup> Such methods allow for systematic TIL enumeration and characterization of the <a href="/wiki/Tumor_microenvironment" title="Tumor microenvironment">tumor microenvironment</a> in diverse cancer types and across thousands of tumors,<sup id="cite_ref-:6_12-1" class="reference"><a href="#cite_note-:6-12">&#91;12&#93;</a></sup><sup id="cite_ref-:3_5-2" class="reference"><a href="#cite_note-:3-5">&#91;5&#93;</a></sup> an approach largely led by <a href="/w/index.php?title=Ash_Alizadeh&amp;action=edit&amp;redlink=1" class="new" title="Ash Alizadeh (page does not exist)">Ash Alizadeh</a>, <a href="/wiki/Ajit_Johnson" title="Ajit Johnson">Ajit Johnson</a> among others. Detection of gene expression specific for different kind of immune cell populations can then be used to determine the degree of lymphocyte infiltration as has been shown in breast cancer.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13">&#91;13&#93;</a></sup> An active immune environment within the tumor often indicates a better prognosis as can be determined by the <a href="/wiki/Immunological_constant_of_rejection" class="mw-redirect" title="Immunological constant of rejection">Immunological constant of rejection</a>.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14">&#91;14&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Use_in_autologous_cell_therapy">Use in autologous cell therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;action=edit&amp;section=2" title="Edit section: Use in autologous cell therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>They are key to an experimental autologous <a href="/wiki/Cell_therapy" title="Cell therapy">cell therapy</a> (Contego) for metastatic melanoma.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15">&#91;15&#93;</a></sup> Autologous TIL therapy for metastatic melanoma has broad T cell recognition of both defined and undefined tumor antigens against all <a href="/wiki/Human_leukocyte_antigen" title="Human leukocyte antigen">human leukocyte antigen (HLA)</a> restrictions. TILs can not only recognize over-expressed self/melanocyte differentiation antigens, such as Melan-A/MART-1 (melanoma-specific), gp100, tyrosinase, and survivin, but TILs can also recognize other unknown antigens specific to the tumor and individual patient.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16">&#91;16&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Use_in_adoptive_T_cell_transfer_therapy">Use in adoptive T cell transfer therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;action=edit&amp;section=3" title="Edit section: Use in adoptive T cell transfer therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;action=edit&amp;section=4" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The use of TILs as an <a href="/wiki/Adoptive_cell_transfer" title="Adoptive cell transfer">adoptive cell transfer</a> therapy to treat cancer was pioneered by Dr. <a href="/wiki/Steven_Rosenberg" title="Steven Rosenberg">Steven Rosenberg</a> and colleagues at the Surgery Branch of the <a href="/wiki/National_Cancer_Institute" title="National Cancer Institute">National Cancer Institute</a> (NCI).<sup id="cite_ref-:4_17-0" class="reference"><a href="#cite_note-:4-17">&#91;17&#93;</a></sup> Rosenberg and colleagues have conducted clinical trials for more than two decades using TIL adoptive cell therapy for melanoma.<sup id="cite_ref-:5_18-0" class="reference"><a href="#cite_note-:5-18">&#91;18&#93;</a></sup> TIL adoptive cell therapy is now a routine regimen in centers across the world, including MD Anderson Cancer Center, where the objective response rates originally observed at the NCI have been reproduced.<sup id="cite_ref-pmid20406835_19-0" class="reference"><a href="#cite_note-pmid20406835-19">&#91;19&#93;</a></sup><sup id="cite_ref-:7_20-0" class="reference"><a href="#cite_note-:7-20">&#91;20&#93;</a></sup> Several centers currently have established TIL therapy protocols for the treatment of melanoma, including the MD Anderson Cancer Center in Houston, Texas,<sup id="cite_ref-:4_17-1" class="reference"><a href="#cite_note-:4-17">&#91;17&#93;</a></sup> Ella Institute in Sheba Hospital, Israel,<sup id="cite_ref-pmid20406835_19-1" class="reference"><a href="#cite_note-pmid20406835-19">&#91;19&#93;</a></sup> and Copenhagen University Hospital in Herlev, Denmark.<sup id="cite_ref-pmid22909342_21-0" class="reference"><a href="#cite_note-pmid22909342-21">&#91;21&#93;</a></sup><sup id="cite_ref-22" class="reference"><a href="#cite_note-22">&#91;22&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Process">Process</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;action=edit&amp;section=5" title="Edit section: Process">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Adoptive_T-cell_therapy.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9e/Adoptive_T-cell_therapy.png/220px-Adoptive_T-cell_therapy.png" decoding="async" width="220" height="165" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/9e/Adoptive_T-cell_therapy.png/330px-Adoptive_T-cell_therapy.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9e/Adoptive_T-cell_therapy.png/440px-Adoptive_T-cell_therapy.png 2x" data-file-width="960" data-file-height="720" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Adoptive_T-cell_therapy.png" class="internal" title="Enlarge"></a></div>Cancer specific T-cells can be obtained by fragmentation and isolation of tumor infiltrating lymphocytes, or by genetically engineering cells from peripheral blood. The cells are activated and grown prior to transfusion into the recipient (tumor bearer).</div></div></div>
<p>In Adoptive T cell transfer therapy, TILs are expanded <i>ex vivo</i> from surgically resected tumors that have been cut into small fragments or from single cell suspensions isolated from the tumor fragments. Multiple individual cultures are established, grown separately and assayed for specific tumor recognition. TILs are expanded over the course of a few weeks with a high dose of <a href="/wiki/IL-2_receptor" title="IL-2 receptor">IL-2</a> in 24-well plates. Selected TIL lines that presented best tumor reactivity are then further expanded in a "rapid expansion protocol" (REP), which uses anti-<a href="/wiki/CD3_(immunology)" title="CD3 (immunology)">CD3</a> activation for a typical period of two weeks. The final post-REP TIL is infused back into the patient. The process can also involve a preliminary chemotherapy regimen to deplete endogenous lymphocytes in order to provide the adoptively transferred TILs with enough access to surround the tumor sites. This chemotherapy regimen is given 7 days before the expanded TIL infusion.<sup id="cite_ref-:4_17-2" class="reference"><a href="#cite_note-:4-17">&#91;17&#93;</a></sup> This involves pretreatment with a combination of <a href="/wiki/Fludarabine" title="Fludarabine">fludarabine</a> and <a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">cyclophosphamide</a>. Lympho-depletion is thought to eliminate the negative effects of other lymphocytes that may compete for growth factors and decrease anti-tumor effects of the TILs, depleting regulatory or inhibitory lymphocyte populations.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23">&#91;23&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Clinical_Success">Clinical Success</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;action=edit&amp;section=6" title="Edit section: Clinical Success">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The combination of TILs with a high dose of IL-2 presents multiple clinical trials demonstrating rates near 50% or more patients effectively responding.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24">&#91;24&#93;</a></sup> In summary of TIL therapy clinical trials, TIL therapy was found to induce complete and durable regression of metastatic melanoma. Tumor reduction of 50% or more was observed in about half of patients.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25">&#91;25&#93;</a></sup><sup id="cite_ref-:7_20-1" class="reference"><a href="#cite_note-:7-20">&#91;20&#93;</a></sup><sup id="cite_ref-26" class="reference"><a href="#cite_note-26">&#91;26&#93;</a></sup><sup id="cite_ref-pmid20406835_19-2" class="reference"><a href="#cite_note-pmid20406835-19">&#91;19&#93;</a></sup> Some patients experienced complete responses with no detectable tumor remaining years after treatment.<sup id="cite_ref-:5_18-1" class="reference"><a href="#cite_note-:5-18">&#91;18&#93;</a></sup> In one clinical trials, among the 93 patients treated with TILs, 19 patients had complete remissions that lasted greater than 3 years.<sup id="cite_ref-:4_17-3" class="reference"><a href="#cite_note-:4-17">&#91;17&#93;</a></sup>
</p><p>Clinical trials using TILs to treat digestive tract cancers, such as <a href="/wiki/Colorectal_cancer" title="Colorectal cancer">colorectal cancer</a>,<sup id="cite_ref-27" class="reference"><a href="#cite_note-27">&#91;27&#93;</a></sup> and cancers associated with the <a href="/wiki/Human_papilloma_virus" class="mw-redirect" title="Human papilloma virus">human papilloma virus</a> (HPV), such as <a href="/wiki/Cervical_cancer" title="Cervical cancer">cervical cancer</a>,<sup id="cite_ref-28" class="reference"><a href="#cite_note-28">&#91;28&#93;</a></sup> are ongoing. In <a href="/wiki/Colorectal_cancer" title="Colorectal cancer">colorectal cancer</a>, TILs are associated with <a href="/wiki/Microsatellite_instability" title="Microsatellite instability">microsatellite instability</a> cancers, as may be seen in <a href="/wiki/Lynch_syndrome" class="mw-redirect" title="Lynch syndrome">Lynch syndrome</a>.<sup id="cite_ref-pmid21114775_29-0" class="reference"><a href="#cite_note-pmid21114775-29">&#91;29&#93;</a></sup> Also, TILs are associated with most effective immune <a href="/wiki/Checkpoint_inhibitor" title="Checkpoint inhibitor">checkpoint inhibitor</a> therapy in GI cancers.<sup id="cite_ref-Shaffer2016_8-2" class="reference"><a href="#cite_note-Shaffer2016-8">&#91;8&#93;</a></sup><sup id="cite_ref-:0_9-1" class="reference"><a href="#cite_note-:0-9">&#91;9&#93;</a></sup> They are an important prognostic factor in <a href="/wiki/Melanoma" title="Melanoma">melanoma</a> and higher levels being associated with a better outcome.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30">&#91;30&#93;</a></sup><sup id="cite_ref-pmid17008531_31-0" class="reference"><a href="#cite_note-pmid17008531-31">&#91;31&#93;</a></sup><sup id="cite_ref-:0_9-2" class="reference"><a href="#cite_note-:0-9">&#91;9&#93;</a></sup> TILs are also associated with better outcomes in <a href="/wiki/Epithelial_ovarian_cancer" class="mw-redirect" title="Epithelial ovarian cancer">epithelial ovarian cancer</a>.<sup id="cite_ref-Zhang2003_7-1" class="reference"><a href="#cite_note-Zhang2003-7">&#91;7&#93;</a></sup><sup id="cite_ref-:0_9-3" class="reference"><a href="#cite_note-:0-9">&#91;9&#93;</a></sup>
</p><p>The use of TILs to treat other tumor types, including lung, ovarian, bladder, and breast, are under investigation.
</p>
<h2><span class="mw-headline" id="Associations_with_cancer_treatments">Associations with cancer treatments</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;action=edit&amp;section=7" title="Edit section: Associations with cancer treatments">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>TIL therapy in combination with prior immunotherapy treatment, such as IL-2 and <a href="/wiki/CTLA-4" title="CTLA-4">anti-CTLA4 (ipilimumab)</a> had higher response rates and more durable responses in clinical trials. This suggests a synergistic effect of prior immunotherapy with TIL therapy.<sup id="cite_ref-:5_18-2" class="reference"><a href="#cite_note-:5-18">&#91;18&#93;</a></sup> Current studies involve investigating the roles of chemotherapy drugs in combination with TIL therapy to assess improved response rates and synergistic efficacy.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32">&#91;32&#93;</a></sup><sup id="cite_ref-33" class="reference"><a href="#cite_note-33">&#91;33&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;action=edit&amp;section=8" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul><li><a href="/wiki/Lymphocyte" title="Lymphocyte">Lymphocyte</a></li>
<li><a href="/wiki/Tumour-infiltrating_dendritic_cell" class="mw-redirect" title="Tumour-infiltrating dendritic cell">Tumor-Infiltrating Dendritic Cell</a></li>
<li><a href="/wiki/Cancer_immunotherapy" title="Cancer immunotherapy">Cancer Immunotherapy</a></li>
<li><a href="/wiki/CAR_T-cell_therapy" class="mw-redirect" title="CAR T-cell therapy">CAR T-Cell therapy</a></li>
<li><a href="/wiki/T_cell" title="T cell">T-cells</a></li></ul>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;action=edit&amp;section=9" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1011085734">.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist reflist-columns references-column-width reflist-columns-2" style="">
<ol class="references">
<li id="cite_note-Teixeira2016-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-Teixeira2016_1-0">^</a></b></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1067248974">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style><cite id="CITEREFTeixeiraRothéIgnatiadisSotiriou2016" class="citation journal cs1">Teixeira, Luis; Rothé, Françoise; Ignatiadis, Michail; Sotiriou, Christos (2016). "Breast Cancer Immunology". <i>Oncology Times</i>. <b>38</b> (9): 18–19. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2F01.COT.0000483221.52404.e3">10.1097/01.COT.0000483221.52404.e3</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:75298788">75298788</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncology+Times&amp;rft.atitle=Breast+Cancer+Immunology&amp;rft.volume=38&amp;rft.issue=9&amp;rft.pages=18-19&amp;rft.date=2016&amp;rft_id=info%3Adoi%2F10.1097%2F01.COT.0000483221.52404.e3&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A75298788%23id-name%3DS2CID&amp;rft.aulast=Teixeira&amp;rft.aufirst=Luis&amp;rft.au=Roth%C3%A9%2C+Fran%C3%A7oise&amp;rft.au=Ignatiadis%2C+Michail&amp;rft.au=Sotiriou%2C+Christos&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-Hanahan2012-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-Hanahan2012_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Hanahan2012_2-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHanahanCoussens2012" class="citation journal cs1">Hanahan D, Coussens LM (March 2012). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ccr.2012.02.022">"Accessories to the crime: functions of cells recruited to the tumor microenvironment"</a>. <i>Cancer Cell</i>. <b>21</b> (3): 309–22. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ccr.2012.02.022">10.1016/j.ccr.2012.02.022</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22439926">22439926</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Cell&amp;rft.atitle=Accessories+to+the+crime%3A+functions+of+cells+recruited+to+the+tumor+microenvironment&amp;rft.volume=21&amp;rft.issue=3&amp;rft.pages=309-22&amp;rft.date=2012-03&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ccr.2012.02.022&amp;rft_id=info%3Apmid%2F22439926&amp;rft.aulast=Hanahan&amp;rft.aufirst=D&amp;rft.au=Coussens%2C+LM&amp;rft_id=%2F%2Fdoi.org%2F10.1016%252Fj.ccr.2012.02.022&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-:1-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-:1_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:1_3-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCoussensZitvogelPalucka2013" class="citation journal cs1">Coussens LM, Zitvogel L, Palucka AK (January 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3591506">"Neutralizing tumor-promoting chronic inflammation: a magic bullet?"</a>. <i>Science</i>. <b>339</b> (6117): 286–91. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2013Sci...339..286C">2013Sci...339..286C</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1126%2Fscience.1232227">10.1126/science.1232227</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3591506">3591506</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23329041">23329041</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Neutralizing+tumor-promoting+chronic+inflammation%3A+a+magic+bullet%3F&amp;rft.volume=339&amp;rft.issue=6117&amp;rft.pages=286-91&amp;rft.date=2013-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3591506%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23329041&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1232227&amp;rft_id=info%3Abibcode%2F2013Sci...339..286C&amp;rft.aulast=Coussens&amp;rft.aufirst=LM&amp;rft.au=Zitvogel%2C+L&amp;rft.au=Palucka%2C+AK&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3591506&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-:2-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-:2_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:2_4-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFEngblomPfirschkeZilionisDa_Silva_Martins2017" class="citation journal cs1">Engblom C, Pfirschke C, Zilionis R, Da Silva Martins J, Bos SA, Courties G, Rickelt S, Severe N, Baryawno N, Faget J, Savova V, Zemmour D, Kline J, Siwicki M, Garris C, Pucci F, Liao HW, Lin YJ, Newton A, Yaghi OK, Iwamoto Y, Tricot B, Wojtkiewicz GR, Nahrendorf M, Cortez-Retamozo V, Meylan E, Hynes RO, Demay M, Klein A, Bredella MA, Scadden DT, Weissleder R, Pittet MJ (December 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6343476">"high neutrophils"</a>. <i>Science</i>. <b>358</b> (6367): eaal5081. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1126%2Fscience.aal5081">10.1126/science.aal5081</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6343476">6343476</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29191879">29191879</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=high+neutrophils&amp;rft.volume=358&amp;rft.issue=6367&amp;rft.pages=eaal5081&amp;rft.date=2017-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6343476%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29191879&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.aal5081&amp;rft.aulast=Engblom&amp;rft.aufirst=C&amp;rft.au=Pfirschke%2C+C&amp;rft.au=Zilionis%2C+R&amp;rft.au=Da+Silva+Martins%2C+J&amp;rft.au=Bos%2C+SA&amp;rft.au=Courties%2C+G&amp;rft.au=Rickelt%2C+S&amp;rft.au=Severe%2C+N&amp;rft.au=Baryawno%2C+N&amp;rft.au=Faget%2C+J&amp;rft.au=Savova%2C+V&amp;rft.au=Zemmour%2C+D&amp;rft.au=Kline%2C+J&amp;rft.au=Siwicki%2C+M&amp;rft.au=Garris%2C+C&amp;rft.au=Pucci%2C+F&amp;rft.au=Liao%2C+HW&amp;rft.au=Lin%2C+YJ&amp;rft.au=Newton%2C+A&amp;rft.au=Yaghi%2C+OK&amp;rft.au=Iwamoto%2C+Y&amp;rft.au=Tricot%2C+B&amp;rft.au=Wojtkiewicz%2C+GR&amp;rft.au=Nahrendorf%2C+M&amp;rft.au=Cortez-Retamozo%2C+V&amp;rft.au=Meylan%2C+E&amp;rft.au=Hynes%2C+RO&amp;rft.au=Demay%2C+M&amp;rft.au=Klein%2C+A&amp;rft.au=Bredella%2C+MA&amp;rft.au=Scadden%2C+DT&amp;rft.au=Weissleder%2C+R&amp;rft.au=Pittet%2C+MJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6343476&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-:3-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-:3_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:3_5-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:3_5-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGentlesNewmanLiuBratman2015" class="citation journal cs1">Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, Diehn M, West RB, Plevritis SK, Alizadeh AA (August 2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4852857">"The prognostic landscape of genes and infiltrating immune cells across human cancers"</a>. <i>Nature Medicine</i>. <b>21</b> (8): 938–945. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnm.3909">10.1038/nm.3909</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4852857">4852857</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26193342">26193342</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Medicine&amp;rft.atitle=The+prognostic+landscape+of+genes+and+infiltrating+immune+cells+across+human+cancers&amp;rft.volume=21&amp;rft.issue=8&amp;rft.pages=938-945&amp;rft.date=2015-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4852857%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26193342&amp;rft_id=info%3Adoi%2F10.1038%2Fnm.3909&amp;rft.aulast=Gentles&amp;rft.aufirst=AJ&amp;rft.au=Newman%2C+AM&amp;rft.au=Liu%2C+CL&amp;rft.au=Bratman%2C+SV&amp;rft.au=Feng%2C+W&amp;rft.au=Kim%2C+D&amp;rft.au=Nair%2C+VS&amp;rft.au=Xu%2C+Y&amp;rft.au=Khuong%2C+A&amp;rft.au=Hoang%2C+CD&amp;rft.au=Diehn%2C+M&amp;rft.au=West%2C+RB&amp;rft.au=Plevritis%2C+SK&amp;rft.au=Alizadeh%2C+AA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4852857&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-Vanky1986-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-Vanky1986_6-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFVánkyKleinWillemsBöök1986" class="citation journal cs1">Vánky F, Klein E, Willems J, Böök K, Ivert T, Péterffy A, Nilsonne U, Kreicbergs A, Aparisi T (1986). "Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery. Correlation with the postsurgical clinical course". <i>Cancer Immunology, Immunotherapy</i>. <b>21</b> (1): 69–76. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2FBF00199380">10.1007/BF00199380</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/3455878">3455878</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:25682924">25682924</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Immunology%2C+Immunotherapy&amp;rft.atitle=Lysis+of+autologous+tumor+cells+by+blood+lymphocytes+tested+at+the+time+of+surgery.+Correlation+with+the+postsurgical+clinical+course&amp;rft.volume=21&amp;rft.issue=1&amp;rft.pages=69-76&amp;rft.date=1986&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A25682924%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F3455878&amp;rft_id=info%3Adoi%2F10.1007%2FBF00199380&amp;rft.aulast=V%C3%A1nky&amp;rft.aufirst=F&amp;rft.au=Klein%2C+E&amp;rft.au=Willems%2C+J&amp;rft.au=B%C3%B6%C3%B6k%2C+K&amp;rft.au=Ivert%2C+T&amp;rft.au=P%C3%A9terffy%2C+A&amp;rft.au=Nilsonne%2C+U&amp;rft.au=Kreicbergs%2C+A&amp;rft.au=Aparisi%2C+T&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-Zhang2003-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-Zhang2003_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Zhang2003_7-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFZhangConejo-GarciaKatsarosGimotty2003" class="citation journal cs1">Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G (January 2003). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190218233438/http://pdfs.semanticscholar.org/150e/3deda6b8428ec4d1659ff005757268bba2f5.pdf">"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer"</a> <span class="cs1-format">(PDF)</span>. <i>The New England Journal of Medicine</i>. <b>348</b> (3): 203–213. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMoa020177">10.1056/NEJMoa020177</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/12529460">12529460</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:23584858">23584858</a>. Archived from <a rel="nofollow" class="external text" href="http://pdfs.semanticscholar.org/150e/3deda6b8428ec4d1659ff005757268bba2f5.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 2019-02-18.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Intratumoral+T+cells%2C+recurrence%2C+and+survival+in+epithelial+ovarian+cancer&amp;rft.volume=348&amp;rft.issue=3&amp;rft.pages=203-213&amp;rft.date=2003-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A23584858%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F12529460&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa020177&amp;rft.aulast=Zhang&amp;rft.aufirst=L&amp;rft.au=Conejo-Garcia%2C+JR&amp;rft.au=Katsaros%2C+D&amp;rft.au=Gimotty%2C+PA&amp;rft.au=Massobrio%2C+M&amp;rft.au=Regnani%2C+G&amp;rft.au=Makrigiannakis%2C+A&amp;rft.au=Gray%2C+H&amp;rft.au=Schlienger%2C+K&amp;rft.au=Liebman%2C+MN&amp;rft.au=Rubin%2C+SC&amp;rft.au=Coukos%2C+G&amp;rft_id=http%3A%2F%2Fpdfs.semanticscholar.org%2F150e%2F3deda6b8428ec4d1659ff005757268bba2f5.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-Shaffer2016-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-Shaffer2016_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Shaffer2016_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Shaffer2016_8-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://global.onclive.com/conference-coverage/SOGO-2016/immunotherapy-doubts-fading-in-gi-cancers">Immunotherapy Doubts Fading in GI Cancers. April 2016</a></span>
</li>
<li id="cite_note-:0-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-:0_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:0_9-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:0_9-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-:0_9-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSynTengMokSoo2017" class="citation journal cs1">Syn NL, Teng MW, Mok TS, Soo RA (December 2017). "De-novo and acquired resistance to immune checkpoint targeting". <i>The Lancet. Oncology</i>. <b>18</b> (12): e731–e741. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs1470-2045%2817%2930607-1">10.1016/s1470-2045(17)30607-1</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29208439">29208439</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Oncology&amp;rft.atitle=De-novo+and+acquired+resistance+to+immune+checkpoint+targeting&amp;rft.volume=18&amp;rft.issue=12&amp;rft.pages=e731-e741&amp;rft.date=2017-12&amp;rft_id=info%3Adoi%2F10.1016%2Fs1470-2045%2817%2930607-1&amp;rft_id=info%3Apmid%2F29208439&amp;rft.aulast=Syn&amp;rft.aufirst=NL&amp;rft.au=Teng%2C+MW&amp;rft.au=Mok%2C+TS&amp;rft.au=Soo%2C+RA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid19638537-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19638537_10-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGargSoslow2009" class="citation journal cs1">Garg K, Soslow RA (August 2009). <a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjcp.2009.064949">"Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma"</a>. <i>Journal of Clinical Pathology</i>. <b>62</b> (8): 679–84. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjcp.2009.064949">10.1136/jcp.2009.064949</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19638537">19638537</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Pathology&amp;rft.atitle=Lynch+syndrome+%28hereditary+non-polyposis+colorectal+cancer%29+and+endometrial+carcinoma&amp;rft.volume=62&amp;rft.issue=8&amp;rft.pages=679-84&amp;rft.date=2009-08&amp;rft_id=info%3Adoi%2F10.1136%2Fjcp.2009.064949&amp;rft_id=info%3Apmid%2F19638537&amp;rft.aulast=Garg&amp;rft.aufirst=K&amp;rft.au=Soslow%2C+RA&amp;rft_id=%2F%2Fdoi.org%2F10.1136%252Fjcp.2009.064949&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFNirmalReganShihHume2018" class="citation journal cs1">Nirmal, Ajit J.; Regan, Tim; Shih, Barbara B.; Hume, David A.; Sims, Andrew H.; Freeman, Tom C. (2018-11-01). <a rel="nofollow" class="external text" href="http://cancerimmunolres.aacrjournals.org/content/6/11/1388">"Immune Cell Gene Signatures for Profiling the Microenvironment of Solid Tumors"</a>. <i>Cancer Immunology Research</i>. <b>6</b> (11): 1388–1400. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1158%2F2326-6066.CIR-18-0342">10.1158/2326-6066.CIR-18-0342</a></span>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/2326-6066">2326-6066</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30266715">30266715</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Immunology+Research&amp;rft.atitle=Immune+Cell+Gene+Signatures+for+Profiling+the+Microenvironment+of+Solid+Tumors&amp;rft.volume=6&amp;rft.issue=11&amp;rft.pages=1388-1400&amp;rft.date=2018-11-01&amp;rft.issn=2326-6066&amp;rft_id=info%3Apmid%2F30266715&amp;rft_id=info%3Adoi%2F10.1158%2F2326-6066.CIR-18-0342&amp;rft.aulast=Nirmal&amp;rft.aufirst=Ajit+J.&amp;rft.au=Regan%2C+Tim&amp;rft.au=Shih%2C+Barbara+B.&amp;rft.au=Hume%2C+David+A.&amp;rft.au=Sims%2C+Andrew+H.&amp;rft.au=Freeman%2C+Tom+C.&amp;rft_id=http%3A%2F%2Fcancerimmunolres.aacrjournals.org%2Fcontent%2F6%2F11%2F1388&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-:6-12"><span class="mw-cite-backlink">^ <a href="#cite_ref-:6_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:6_12-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFNewmanLiuGreenGentles2015" class="citation journal cs1">Newman, Aaron M; Liu, Chih Long; Green, Michael R; Gentles, Andrew J; Feng, Weiguo; Xu, Yue; Hoang, Chuong D; Diehn, Maximilian; Alizadeh, Ash A (2015-03-30). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4739640">"Robust enumeration of cell subsets from tissue expression profiles"</a>. <i>Nature Methods</i>. <b>12</b> (5): 453–457. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnmeth.3337">10.1038/nmeth.3337</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1548-7091">1548-7091</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4739640">4739640</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25822800">25822800</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Methods&amp;rft.atitle=Robust+enumeration+of+cell+subsets+from+tissue+expression+profiles&amp;rft.volume=12&amp;rft.issue=5&amp;rft.pages=453-457&amp;rft.date=2015-03-30&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4739640%23id-name%3DPMC&amp;rft.issn=1548-7091&amp;rft_id=info%3Apmid%2F25822800&amp;rft_id=info%3Adoi%2F10.1038%2Fnmeth.3337&amp;rft.aulast=Newman&amp;rft.aufirst=Aaron+M&amp;rft.au=Liu%2C+Chih+Long&amp;rft.au=Green%2C+Michael+R&amp;rft.au=Gentles%2C+Andrew+J&amp;rft.au=Feng%2C+Weiguo&amp;rft.au=Xu%2C+Yue&amp;rft.au=Hoang%2C+Chuong+D&amp;rft.au=Diehn%2C+Maximilian&amp;rft.au=Alizadeh%2C+Ash+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4739640&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBedognettiHendrickxMarincolaMiller2015" class="citation journal cs1">Bedognetti D, Hendrickx W, Marincola FM, Miller LD (November 2015). "Prognostic and predictive immune gene signatures in breast cancer". <i>Current Opinion in Oncology</i>. <b>27</b> (6): 433–44. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2Fcco.0000000000000234">10.1097/cco.0000000000000234</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26418235">26418235</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:30713069">30713069</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Oncology&amp;rft.atitle=Prognostic+and+predictive+immune+gene+signatures+in+breast+cancer&amp;rft.volume=27&amp;rft.issue=6&amp;rft.pages=433-44&amp;rft.date=2015-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A30713069%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F26418235&amp;rft_id=info%3Adoi%2F10.1097%2Fcco.0000000000000234&amp;rft.aulast=Bedognetti&amp;rft.aufirst=D&amp;rft.au=Hendrickx%2C+W&amp;rft.au=Marincola%2C+FM&amp;rft.au=Miller%2C+LD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBedognettiHendrickxCeccarelliMiller2016" class="citation journal cs1">Bedognetti D, Hendrickx W, Ceccarelli M, Miller LD, Seliger B (April 2016). "Disentangling the relationship between tumor genetic programs and immune responsiveness". <i>Current Opinion in Immunology</i>. <b>39</b>: 150–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.coi.2016.02.001">10.1016/j.coi.2016.02.001</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26967649">26967649</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Immunology&amp;rft.atitle=Disentangling+the+relationship+between+tumor+genetic+programs+and+immune+responsiveness&amp;rft.volume=39&amp;rft.pages=150-8&amp;rft.date=2016-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.coi.2016.02.001&amp;rft_id=info%3Apmid%2F26967649&amp;rft.aulast=Bedognetti&amp;rft.aufirst=D&amp;rft.au=Hendrickx%2C+W&amp;rft.au=Ceccarelli%2C+M&amp;rft.au=Miller%2C+LD&amp;rft.au=Seliger%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation news cs1"><a rel="nofollow" class="external text" href="http://www.news-medical.net/news/20110606/Genesis-Biopharma-expands-clinical-focus-to-develop-Contego-for-Stage-IV-metastatic-melanoma.aspx">"Genesis Biopharma expands clinical focus to develop Contego for Stage IV metastatic melanoma"</a>. June 2011.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Genesis+Biopharma+expands+clinical+focus+to+develop+Contego+for+Stage+IV+metastatic+melanoma&amp;rft.date=2011-06&amp;rft_id=http%3A%2F%2Fwww.news-medical.net%2Fnews%2F20110606%2FGenesis-Biopharma-expands-clinical-focus-to-develop-Contego-for-Stage-IV-metastatic-melanoma.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFRestifoDudleyRosenberg2012" class="citation journal cs1">Restifo NP, Dudley ME, Rosenberg SA (March 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6292222">"Adoptive immunotherapy for cancer: harnessing the T cell response"</a>. <i>Nature Reviews. Immunology</i>. <b>12</b> (4): 269–81. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnri3191">10.1038/nri3191</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6292222">6292222</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22437939">22437939</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Immunology&amp;rft.atitle=Adoptive+immunotherapy+for+cancer%3A+harnessing+the+T+cell+response&amp;rft.volume=12&amp;rft.issue=4&amp;rft.pages=269-81&amp;rft.date=2012-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6292222%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22437939&amp;rft_id=info%3Adoi%2F10.1038%2Fnri3191&amp;rft.aulast=Restifo&amp;rft.aufirst=NP&amp;rft.au=Dudley%2C+ME&amp;rft.au=Rosenberg%2C+SA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6292222&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-:4-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-:4_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:4_17-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:4_17-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-:4_17-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLizéeOverwijkRadvanyiGao2013" class="citation journal cs1">Lizée G, Overwijk WW, Radvanyi L, Gao J, Sharma P, Hwu P (2013-01-14). "Harnessing the power of the immune system to target cancer". <i>Annual Review of Medicine</i>. <b>64</b> (1): 71–90. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1146%2Fannurev-med-112311-083918">10.1146/annurev-med-112311-083918</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23092383">23092383</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annual+Review+of+Medicine&amp;rft.atitle=Harnessing+the+power+of+the+immune+system+to+target+cancer&amp;rft.volume=64&amp;rft.issue=1&amp;rft.pages=71-90&amp;rft.date=2013-01-14&amp;rft_id=info%3Adoi%2F10.1146%2Fannurev-med-112311-083918&amp;rft_id=info%3Apmid%2F23092383&amp;rft.aulast=Liz%C3%A9e&amp;rft.aufirst=G&amp;rft.au=Overwijk%2C+WW&amp;rft.au=Radvanyi%2C+L&amp;rft.au=Gao%2C+J&amp;rft.au=Sharma%2C+P&amp;rft.au=Hwu%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-:5-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-:5_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:5_18-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:5_18-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFRosenbergYangSherryKammula2011" class="citation journal cs1">Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, Phan GQ, Citrin DE, Restifo NP, Robbins PF, Wunderlich JR, Morton KE, Laurencot CM, Steinberg SM, White DE, Dudley ME (July 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3131487">"Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy"</a>. <i>Clinical Cancer Research</i>. <b>17</b> (13): 4550–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1158%2F1078-0432.CCR-11-0116">10.1158/1078-0432.CCR-11-0116</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3131487">3131487</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21498393">21498393</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Cancer+Research&amp;rft.atitle=Durable+complete+responses+in+heavily+pretreated+patients+with+metastatic+melanoma+using+T-cell+transfer+immunotherapy&amp;rft.volume=17&amp;rft.issue=13&amp;rft.pages=4550-7&amp;rft.date=2011-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3131487%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21498393&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-11-0116&amp;rft.aulast=Rosenberg&amp;rft.aufirst=SA&amp;rft.au=Yang%2C+JC&amp;rft.au=Sherry%2C+RM&amp;rft.au=Kammula%2C+US&amp;rft.au=Hughes%2C+MS&amp;rft.au=Phan%2C+GQ&amp;rft.au=Citrin%2C+DE&amp;rft.au=Restifo%2C+NP&amp;rft.au=Robbins%2C+PF&amp;rft.au=Wunderlich%2C+JR&amp;rft.au=Morton%2C+KE&amp;rft.au=Laurencot%2C+CM&amp;rft.au=Steinberg%2C+SM&amp;rft.au=White%2C+DE&amp;rft.au=Dudley%2C+ME&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3131487&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid20406835-19"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid20406835_19-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20406835_19-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid20406835_19-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBesserShapira-FrommerTrevesZippel2010" class="citation journal cs1">Besser MJ, Shapira-Frommer R, Treves AJ, Zippel D, Itzhaki O, Hershkovitz L, Levy D, Kubi A, Hovav E, Chermoshniuk N, Shalmon B, Hardan I, Catane R, Markel G, Apter S, Ben-Nun A, Kuchuk I, Shimoni A, Nagler A, Schachter J (May 2010). <a rel="nofollow" class="external text" href="https://doi.org/10.1158%2F1078-0432.CCR-10-0041">"Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients"</a>. <i>Clinical Cancer Research</i>. <b>16</b> (9): 2646–55. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1158%2F1078-0432.CCR-10-0041">10.1158/1078-0432.CCR-10-0041</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20406835">20406835</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Cancer+Research&amp;rft.atitle=Clinical+responses+in+a+phase+II+study+using+adoptive+transfer+of+short-term+cultured+tumor+infiltration+lymphocytes+in+metastatic+melanoma+patients&amp;rft.volume=16&amp;rft.issue=9&amp;rft.pages=2646-55&amp;rft.date=2010-05&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-10-0041&amp;rft_id=info%3Apmid%2F20406835&amp;rft.aulast=Besser&amp;rft.aufirst=MJ&amp;rft.au=Shapira-Frommer%2C+R&amp;rft.au=Treves%2C+AJ&amp;rft.au=Zippel%2C+D&amp;rft.au=Itzhaki%2C+O&amp;rft.au=Hershkovitz%2C+L&amp;rft.au=Levy%2C+D&amp;rft.au=Kubi%2C+A&amp;rft.au=Hovav%2C+E&amp;rft.au=Chermoshniuk%2C+N&amp;rft.au=Shalmon%2C+B&amp;rft.au=Hardan%2C+I&amp;rft.au=Catane%2C+R&amp;rft.au=Markel%2C+G&amp;rft.au=Apter%2C+S&amp;rft.au=Ben-Nun%2C+A&amp;rft.au=Kuchuk%2C+I&amp;rft.au=Shimoni%2C+A&amp;rft.au=Nagler%2C+A&amp;rft.au=Schachter%2C+J&amp;rft_id=%2F%2Fdoi.org%2F10.1158%252F1078-0432.CCR-10-0041&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-:7-20"><span class="mw-cite-backlink">^ <a href="#cite_ref-:7_20-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:7_20-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFRadvanyiBernatchezZhangFox2012" class="citation journal cs1">Radvanyi LG, Bernatchez C, Zhang M, Fox PS, Miller P, Chacon J, Wu R, Lizee G, Mahoney S, Alvarado G, Glass M, Johnson VE, McMannis JD, Shpall E, Prieto V, Papadopoulos N, Kim K, Homsi J, Bedikian A, Hwu WJ, Patel S, Ross MI, Lee JE, Gershenwald JE, Lucci A, Royal R, Cormier JN, Davies MA, Mansaray R, Fulbright OJ, Toth C, Ramachandran R, Wardell S, Gonzalez A, Hwu P (December 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3525747">"Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients"</a>. <i>Clinical Cancer Research</i>. <b>18</b> (24): 6758–70. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1158%2F1078-0432.CCR-12-1177">10.1158/1078-0432.CCR-12-1177</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3525747">3525747</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23032743">23032743</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Cancer+Research&amp;rft.atitle=Specific+lymphocyte+subsets+predict+response+to+adoptive+cell+therapy+using+expanded+autologous+tumor-infiltrating+lymphocytes+in+metastatic+melanoma+patients&amp;rft.volume=18&amp;rft.issue=24&amp;rft.pages=6758-70&amp;rft.date=2012-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3525747%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23032743&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-12-1177&amp;rft.aulast=Radvanyi&amp;rft.aufirst=LG&amp;rft.au=Bernatchez%2C+C&amp;rft.au=Zhang%2C+M&amp;rft.au=Fox%2C+PS&amp;rft.au=Miller%2C+P&amp;rft.au=Chacon%2C+J&amp;rft.au=Wu%2C+R&amp;rft.au=Lizee%2C+G&amp;rft.au=Mahoney%2C+S&amp;rft.au=Alvarado%2C+G&amp;rft.au=Glass%2C+M&amp;rft.au=Johnson%2C+VE&amp;rft.au=McMannis%2C+JD&amp;rft.au=Shpall%2C+E&amp;rft.au=Prieto%2C+V&amp;rft.au=Papadopoulos%2C+N&amp;rft.au=Kim%2C+K&amp;rft.au=Homsi%2C+J&amp;rft.au=Bedikian%2C+A&amp;rft.au=Hwu%2C+WJ&amp;rft.au=Patel%2C+S&amp;rft.au=Ross%2C+MI&amp;rft.au=Lee%2C+JE&amp;rft.au=Gershenwald%2C+JE&amp;rft.au=Lucci%2C+A&amp;rft.au=Royal%2C+R&amp;rft.au=Cormier%2C+JN&amp;rft.au=Davies%2C+MA&amp;rft.au=Mansaray%2C+R&amp;rft.au=Fulbright%2C+OJ&amp;rft.au=Toth%2C+C&amp;rft.au=Ramachandran%2C+R&amp;rft.au=Wardell%2C+S&amp;rft.au=Gonzalez%2C+A&amp;rft.au=Hwu%2C+P&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3525747&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid22909342-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22909342_21-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFEllebaekIversenJunkerDonia2012" class="citation journal cs1">Ellebaek E, Iversen TZ, Junker N, Donia M, Engell-Noerregaard L, Met Ö, Hölmich LR, Andersen RS, Hadrup SR, Andersen MH, thor Straten P, Svane IM (August 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3514199">"Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients"</a>. <i>Journal of Translational Medicine</i>. <b>10</b>: 169. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2F1479-5876-10-169">10.1186/1479-5876-10-169</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3514199">3514199</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22909342">22909342</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Translational+Medicine&amp;rft.atitle=Adoptive+cell+therapy+with+autologous+tumor+infiltrating+lymphocytes+and+low-dose+Interleukin-2+in+metastatic+melanoma+patients&amp;rft.volume=10&amp;rft.pages=169&amp;rft.date=2012-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3514199%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22909342&amp;rft_id=info%3Adoi%2F10.1186%2F1479-5876-10-169&amp;rft.aulast=Ellebaek&amp;rft.aufirst=E&amp;rft.au=Iversen%2C+TZ&amp;rft.au=Junker%2C+N&amp;rft.au=Donia%2C+M&amp;rft.au=Engell-Noerregaard%2C+L&amp;rft.au=Met%2C+%C3%96&amp;rft.au=H%C3%B6lmich%2C+LR&amp;rft.au=Andersen%2C+RS&amp;rft.au=Hadrup%2C+SR&amp;rft.au=Andersen%2C+MH&amp;rft.au=thor+Straten%2C+P&amp;rft.au=Svane%2C+IM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3514199&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDoniaHansenSendrupIversen2013" class="citation journal cs1">Donia M, Hansen M, Sendrup SL, Iversen TZ, Ellebæk E, Andersen MH, Straten P, Svane IM (February 2013). <a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fjid.2012.336">"Methods to improve adoptive T-cell therapy for melanoma: IFN-γ enhances anticancer responses of cell products for infusion"</a>. <i>The Journal of Investigative Dermatology</i>. <b>133</b> (2): 545–52. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fjid.2012.336">10.1038/jid.2012.336</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23014345">23014345</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Investigative+Dermatology&amp;rft.atitle=Methods+to+improve+adoptive+T-cell+therapy+for+melanoma%3A+IFN-%CE%B3+enhances+anticancer+responses+of+cell+products+for+infusion&amp;rft.volume=133&amp;rft.issue=2&amp;rft.pages=545-52&amp;rft.date=2013-02&amp;rft_id=info%3Adoi%2F10.1038%2Fjid.2012.336&amp;rft_id=info%3Apmid%2F23014345&amp;rft.aulast=Donia&amp;rft.aufirst=M&amp;rft.au=Hansen%2C+M&amp;rft.au=Sendrup%2C+SL&amp;rft.au=Iversen%2C+TZ&amp;rft.au=Elleb%C3%A6k%2C+E&amp;rft.au=Andersen%2C+MH&amp;rft.au=Straten%2C+P&amp;rft.au=Svane%2C+IM&amp;rft_id=%2F%2Fdoi.org%2F10.1038%252Fjid.2012.336&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGattinoniFinkelsteinKlebanoffAntony2005" class="citation journal cs1">Gattinoni L, Finkelstein SE, Klebanoff CA, Antony PA, Palmer DC, Spiess PJ, Hwang LN, Yu Z, Wrzesinski C, Heimann DM, Surh CD, Rosenberg SA, Restifo NP (October 2005). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1397916">"Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells"</a>. <i>The Journal of Experimental Medicine</i>. <b>202</b> (7): 907–12. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1084%2Fjem.20050732">10.1084/jem.20050732</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1397916">1397916</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16203864">16203864</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Experimental+Medicine&amp;rft.atitle=Removal+of+homeostatic+cytokine+sinks+by+lymphodepletion+enhances+the+efficacy+of+adoptively+transferred+tumor-specific+CD8%2B+T+cells&amp;rft.volume=202&amp;rft.issue=7&amp;rft.pages=907-12&amp;rft.date=2005-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1397916%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F16203864&amp;rft_id=info%3Adoi%2F10.1084%2Fjem.20050732&amp;rft.aulast=Gattinoni&amp;rft.aufirst=L&amp;rft.au=Finkelstein%2C+SE&amp;rft.au=Klebanoff%2C+CA&amp;rft.au=Antony%2C+PA&amp;rft.au=Palmer%2C+DC&amp;rft.au=Spiess%2C+PJ&amp;rft.au=Hwang%2C+LN&amp;rft.au=Yu%2C+Z&amp;rft.au=Wrzesinski%2C+C&amp;rft.au=Heimann%2C+DM&amp;rft.au=Surh%2C+CD&amp;rft.au=Rosenberg%2C+SA&amp;rft.au=Restifo%2C+NP&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1397916&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDudleyRosenberg2003" class="citation journal cs1">Dudley ME, Rosenberg SA (September 2003). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2305722">"Adoptive-cell-transfer therapy for the treatment of patients with cancer"</a>. <i>Nature Reviews. Cancer</i>. <b>3</b> (9): 666–75. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrc1167">10.1038/nrc1167</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2305722">2305722</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/12951585">12951585</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Cancer&amp;rft.atitle=Adoptive-cell-transfer+therapy+for+the+treatment+of+patients+with+cancer&amp;rft.volume=3&amp;rft.issue=9&amp;rft.pages=666-75&amp;rft.date=2003-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2305722%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12951585&amp;rft_id=info%3Adoi%2F10.1038%2Fnrc1167&amp;rft.aulast=Dudley&amp;rft.aufirst=ME&amp;rft.au=Rosenberg%2C+SA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2305722&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDudleyYangSherryHughes2008" class="citation journal cs1">Dudley ME, Yang JC, Sherry R, Hughes MS, Royal R, Kammula U, Robbins PF, Huang J, Citrin DE, Leitman SF, Wunderlich J, Restifo NP, Thomasian A, Downey SG, Smith FO, Klapper J, Morton K, Laurencot C, White DE, Rosenberg SA (November 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2652090">"Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens"</a>. <i>Journal of Clinical Oncology</i>. <b>26</b> (32): 5233–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1200%2FJCO.2008.16.5449">10.1200/JCO.2008.16.5449</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2652090">2652090</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18809613">18809613</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Oncology&amp;rft.atitle=Adoptive+cell+therapy+for+patients+with+metastatic+melanoma%3A+evaluation+of+intensive+myeloablative+chemoradiation+preparative+regimens&amp;rft.volume=26&amp;rft.issue=32&amp;rft.pages=5233-9&amp;rft.date=2008-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2652090%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F18809613&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2008.16.5449&amp;rft.aulast=Dudley&amp;rft.aufirst=ME&amp;rft.au=Yang%2C+JC&amp;rft.au=Sherry%2C+R&amp;rft.au=Hughes%2C+MS&amp;rft.au=Royal%2C+R&amp;rft.au=Kammula%2C+U&amp;rft.au=Robbins%2C+PF&amp;rft.au=Huang%2C+J&amp;rft.au=Citrin%2C+DE&amp;rft.au=Leitman%2C+SF&amp;rft.au=Wunderlich%2C+J&amp;rft.au=Restifo%2C+NP&amp;rft.au=Thomasian%2C+A&amp;rft.au=Downey%2C+SG&amp;rft.au=Smith%2C+FO&amp;rft.au=Klapper%2C+J&amp;rft.au=Morton%2C+K&amp;rft.au=Laurencot%2C+C&amp;rft.au=White%2C+DE&amp;rft.au=Rosenberg%2C+SA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2652090&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFPilon-ThomasKuhnEllwangerJanssen2012" class="citation journal cs1">Pilon-Thomas S, Kuhn L, Ellwanger S, Janssen W, Royster E, Marzban S, Kudchadkar R, Zager J, Gibney G, Sondak VK, Weber J, Mulé JJ, Sarnaik AA (October 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4467830">"Efficacy of adoptive cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanoma"</a>. <i>Journal of Immunotherapy</i>. <b>35</b> (8): 615–20. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FCJI.0b013e31826e8f5f">10.1097/CJI.0b013e31826e8f5f</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4467830">4467830</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22996367">22996367</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Immunotherapy&amp;rft.atitle=Efficacy+of+adoptive+cell+transfer+of+tumor-infiltrating+lymphocytes+after+lymphopenia+induction+for+metastatic+melanoma&amp;rft.volume=35&amp;rft.issue=8&amp;rft.pages=615-20&amp;rft.date=2012-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4467830%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22996367&amp;rft_id=info%3Adoi%2F10.1097%2FCJI.0b013e31826e8f5f&amp;rft.aulast=Pilon-Thomas&amp;rft.aufirst=S&amp;rft.au=Kuhn%2C+L&amp;rft.au=Ellwanger%2C+S&amp;rft.au=Janssen%2C+W&amp;rft.au=Royster%2C+E&amp;rft.au=Marzban%2C+S&amp;rft.au=Kudchadkar%2C+R&amp;rft.au=Zager%2C+J&amp;rft.au=Gibney%2C+G&amp;rft.au=Sondak%2C+VK&amp;rft.au=Weber%2C+J&amp;rft.au=Mul%C3%A9%2C+JJ&amp;rft.au=Sarnaik%2C+AA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4467830&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text">Clinical trial number <i><a rel="nofollow" class="external text" href="https://www.clinicaltrials.gov/show/NCT01174121">NCT01174121</a></i> for "A Phase II Study Using Short-Term Cultured, CD8+-Enriched Autologous Tumor-infiltrating Lymphocytes Following a Lymphocyte Depleting Regimen in Metastatic Digestive Tract Cancers" at <a href="/wiki/ClinicalTrials.gov" title="ClinicalTrials.gov">ClinicalTrials.gov</a></span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text">Clinical trial number <i><a rel="nofollow" class="external text" href="https://www.clinicaltrials.gov/show/NCT01585428">NCT01585428</a></i> for "A Phase II Study of Lymphodepletion Followed by Autologous Tumor-Infiltrating Lymphocytes and High-Dose Adesleukin for Human Papillomavirus-Associated Cancers" at <a href="/wiki/ClinicalTrials.gov" title="ClinicalTrials.gov">ClinicalTrials.gov</a></span>
</li>
<li id="cite_note-pmid21114775-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21114775_29-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFIacopettaGrieuAmanuel2010" class="citation journal cs1">Iacopetta B, Grieu F, Amanuel B (December 2010). <a rel="nofollow" class="external text" href="https://zenodo.org/record/895588">"Microsatellite instability in colorectal cancer"</a>. <i>Asia-Pacific Journal of Clinical Oncology</i>. <b>6</b> (4): 260–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1743-7563.2010.01335.x">10.1111/j.1743-7563.2010.01335.x</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21114775">21114775</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Asia-Pacific+Journal+of+Clinical+Oncology&amp;rft.atitle=Microsatellite+instability+in+colorectal+cancer&amp;rft.volume=6&amp;rft.issue=4&amp;rft.pages=260-9&amp;rft.date=2010-12&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1743-7563.2010.01335.x&amp;rft_id=info%3Apmid%2F21114775&amp;rft.aulast=Iacopetta&amp;rft.aufirst=B&amp;rft.au=Grieu%2C+F&amp;rft.au=Amanuel%2C+B&amp;rft_id=https%3A%2F%2Fzenodo.org%2Frecord%2F895588&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSpatz2007" class="citation web cs1">Spatz;  et&#160;al. (2007). <a rel="nofollow" class="external text" href="http://www.asco.org/ascov2/Meetings/Abstracts?&amp;vmview=abst_detail_view&amp;confID=47&amp;abstractID=34439">"Protective effect of a brisk tumor infiltrating lymphocyte infiltrate in melanoma: An EORTC melanoma group study"</a>. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 8519.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Protective+effect+of+a+brisk+tumor+infiltrating+lymphocyte+infiltrate+in+melanoma%3A+An+EORTC+melanoma+group+study.&amp;rft.pub=Journal+of+Clinical+Oncology%2C+2007+ASCO+Annual+Meeting+Proceedings+Part+I.+Vol+25%2C+No.+18S+%28June+20+Supplement%29%2C+2007%3A+8519&amp;rft.date=2007&amp;rft.au=Spatz&amp;rft_id=http%3A%2F%2Fwww.asco.org%2Fascov2%2FMeetings%2FAbstracts%3F%26vmview%3Dabst_detail_view%26confID%3D47%26abstractID%3D34439&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid17008531-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17008531_31-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGalonCostesSanchez-CaboKirilovsky2006" class="citation journal cs1">Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pagès F (September 2006). "Type, density, and location of immune cells within human colorectal tumors predict clinical outcome". <i>Science</i>. <b>313</b> (5795): 1960–4. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2006Sci...313.1960G">2006Sci...313.1960G</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1126%2Fscience.1129139">10.1126/science.1129139</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/17008531">17008531</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:473931">473931</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Type%2C+density%2C+and+location+of+immune+cells+within+human+colorectal+tumors+predict+clinical+outcome&amp;rft.volume=313&amp;rft.issue=5795&amp;rft.pages=1960-4&amp;rft.date=2006-09&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1129139&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A473931%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F17008531&amp;rft_id=info%3Abibcode%2F2006Sci...313.1960G&amp;rft.aulast=Galon&amp;rft.aufirst=J&amp;rft.au=Costes%2C+A&amp;rft.au=Sanchez-Cabo%2C+F&amp;rft.au=Kirilovsky%2C+A&amp;rft.au=Mlecnik%2C+B&amp;rft.au=Lagorce-Pag%C3%A8s%2C+C&amp;rft.au=Tosolini%2C+M&amp;rft.au=Camus%2C+M&amp;rft.au=Berger%2C+A&amp;rft.au=Wind%2C+P&amp;rft.au=Zinzindohou%C3%A9%2C+F&amp;rft.au=Bruneval%2C+P&amp;rft.au=Cugnenc%2C+PH&amp;rft.au=Trajanoski%2C+Z&amp;rft.au=Fridman%2C+WH&amp;rft.au=Pag%C3%A8s%2C+F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMbofungMcKenzieMaluZhang2017" class="citation journal cs1">Mbofung RM, McKenzie JA, Malu S, Zhang M, Peng W, Liu C, Kuiatse I, Tieu T, Williams L, Devi S, Ashkin E, Xu C, Huang L, Zhang M, Talukder AH, Tripathi SC, Khong H, Satani N, Muller FL, Roszik J, Heffernan T, Allison JP, Lizee G, Hanash SM, Proia D, Amaria R, Davis RE, Hwu P (September 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5587668">"HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes"</a>. <i>Nature Communications</i>. <b>8</b> (1): 451. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2017NatCo...8..451M">2017NatCo...8..451M</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41467-017-00449-z">10.1038/s41467-017-00449-z</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5587668">5587668</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28878208">28878208</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Communications&amp;rft.atitle=HSP90+inhibition+enhances+cancer+immunotherapy+by+upregulating+interferon+response+genes&amp;rft.volume=8&amp;rft.issue=1&amp;rft.pages=451&amp;rft.date=2017-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5587668%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28878208&amp;rft_id=info%3Adoi%2F10.1038%2Fs41467-017-00449-z&amp;rft_id=info%3Abibcode%2F2017NatCo...8..451M&amp;rft.aulast=Mbofung&amp;rft.aufirst=RM&amp;rft.au=McKenzie%2C+JA&amp;rft.au=Malu%2C+S&amp;rft.au=Zhang%2C+M&amp;rft.au=Peng%2C+W&amp;rft.au=Liu%2C+C&amp;rft.au=Kuiatse%2C+I&amp;rft.au=Tieu%2C+T&amp;rft.au=Williams%2C+L&amp;rft.au=Devi%2C+S&amp;rft.au=Ashkin%2C+E&amp;rft.au=Xu%2C+C&amp;rft.au=Huang%2C+L&amp;rft.au=Zhang%2C+M&amp;rft.au=Talukder%2C+AH&amp;rft.au=Tripathi%2C+SC&amp;rft.au=Khong%2C+H&amp;rft.au=Satani%2C+N&amp;rft.au=Muller%2C+FL&amp;rft.au=Roszik%2C+J&amp;rft.au=Heffernan%2C+T&amp;rft.au=Allison%2C+JP&amp;rft.au=Lizee%2C+G&amp;rft.au=Hanash%2C+SM&amp;rft.au=Proia%2C+D&amp;rft.au=Amaria%2C+R&amp;rft.au=Davis%2C+RE&amp;rft.au=Hwu%2C+P&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5587668&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMcKenzieMbofungMaluZhang2017" class="citation journal cs1">McKenzie JA, Mbofung RM, Malu S, Zhang M, Ashkin E, Devi S, Williams L, Tieu T, Peng W, Pradeep S, Xu C, Zorro Manrique S, Liu C, Huang L, Chen Y, Forget MA, Haymaker C, Bernatchez C, Satani N, Muller F, Roszik J, Kalra A, Heffernan T, Sood A, Hu J, Amaria R, Davis RE, Hwu P (December 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6037061">"The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy"</a>. <i>Journal of the National Cancer Institute</i>. <b>110</b> (7): 777–786. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fjnci%2Fdjx257">10.1093/jnci/djx257</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6037061">6037061</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29267866">29267866</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+National+Cancer+Institute&amp;rft.atitle=The+Effect+of+Topoisomerase+I+Inhibitors+on+the+Efficacy+of+T-Cell-Based+Cancer+Immunotherapy&amp;rft.volume=110&amp;rft.issue=7&amp;rft.pages=777-786&amp;rft.date=2017-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6037061%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29267866&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2Fdjx257&amp;rft.aulast=McKenzie&amp;rft.aufirst=JA&amp;rft.au=Mbofung%2C+RM&amp;rft.au=Malu%2C+S&amp;rft.au=Zhang%2C+M&amp;rft.au=Ashkin%2C+E&amp;rft.au=Devi%2C+S&amp;rft.au=Williams%2C+L&amp;rft.au=Tieu%2C+T&amp;rft.au=Peng%2C+W&amp;rft.au=Pradeep%2C+S&amp;rft.au=Xu%2C+C&amp;rft.au=Zorro+Manrique%2C+S&amp;rft.au=Liu%2C+C&amp;rft.au=Huang%2C+L&amp;rft.au=Chen%2C+Y&amp;rft.au=Forget%2C+MA&amp;rft.au=Haymaker%2C+C&amp;rft.au=Bernatchez%2C+C&amp;rft.au=Satani%2C+N&amp;rft.au=Muller%2C+F&amp;rft.au=Roszik%2C+J&amp;rft.au=Kalra%2C+A&amp;rft.au=Heffernan%2C+T&amp;rft.au=Sood%2C+A&amp;rft.au=Hu%2C+J&amp;rft.au=Amaria%2C+R&amp;rft.au=Davis%2C+RE&amp;rft.au=Hwu%2C+P&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6037061&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor-infiltrating+lymphocytes" class="Z3988"></span></span>
</li>
</ol></div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;action=edit&amp;section=10" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul><li><a rel="nofollow" class="external text" href="http://www.cancer.gov/dictionary?CdrID=45329">Tumor infiltrating lymphocyte</a> entry in the public domain NCI Dictionary of Cancer Terms</li>
<li><a rel="nofollow" class="external text" href="http://www.lbio.com/">Lion Biotechnologies, Inc.</a></li></ul>
<!-- 
NewPP limit report
Parsed by mw1435
Cached time: 20220323231705
Cache expiry: 1814400
Reduced expiry: false
Complications: [vary‐revision‐sha1]
CPU time usage: 0.423 seconds
Real time usage: 0.459 seconds
Preprocessor visited node count: 1692/1000000
Post‐expand include size: 94155/2097152 bytes
Template argument size: 818/2097152 bytes
Highest expansion depth: 8/100
Expensive parser function count: 0/500
Unstrip recursion depth: 1/20
Unstrip post‐expand size: 121031/5000000 bytes
Lua time usage: 0.224/10.000 seconds
Lua memory usage: 4094097/52428800 bytes
Number of Wikibase entities loaded: 0/400
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  354.968      1 -total
100.00%  354.968      1 Template:Reflist
 74.37%  264.000     28 Template:Cite_journal
  1.52%    5.392      1 Template:Cite_news
  1.37%    4.849      1 Template:Cite_web
  1.03%    3.655      1 Template:Main_other
  0.48%    1.696      2 Template:ClinicalTrialsGov
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:14580464-0!canonical and timestamp 20220323231704 and revision id 1060517838. Serialized with JSON.
 -->
</div><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript>
<div class="printfooter">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;oldid=1060517838">https://en.wikipedia.org/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;oldid=1060517838</a>"</div></div>
		<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Lymphocytes" title="Category:Lymphocytes">Lymphocytes</a></li><li><a href="/wiki/Category:Oncology" title="Category:Oncology">Oncology</a></li></ul></div></div>
	</div>
</div>
<div id='mw-data-after-content'>
	<div class="read-more-container"></div>
</div>

<div id="mw-navigation">
	<h2>Navigation menu</h2>
	<div id="mw-head">
		
<nav id="p-personal" class="mw-portlet mw-portlet-personal vector-user-menu-legacy vector-menu" aria-labelledby="p-personal-label" role="navigation" 
	 >
	<label id="p-personal-label" aria-label="" class="vector-menu-heading">
		<span class="vector-menu-heading-label">Personal tools</span>
	</label>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="pt-anonuserpage" class="mw-list-item"><span>Not logged in</span></li><li id="pt-anontalk" class="mw-list-item"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n"><span>Talk</span></a></li><li id="pt-anoncontribs" class="mw-list-item"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y"><span>Contributions</span></a></li><li id="pt-createaccount" class="mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Tumor-infiltrating+lymphocytes" title="You are encouraged to create an account and log in; however, it is not mandatory"><span>Create account</span></a></li><li id="pt-login" class="mw-list-item"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Tumor-infiltrating+lymphocytes" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o"><span>Log in</span></a></li></ul>
		
	</div>
</nav>

		<div id="left-navigation">
			
<nav id="p-namespaces" class="mw-portlet mw-portlet-namespaces vector-menu vector-menu-tabs" aria-labelledby="p-namespaces-label" role="navigation" 
	 >
	<label id="p-namespaces-label" aria-label="" class="vector-menu-heading">
		<span class="vector-menu-heading-label">Namespaces</span>
	</label>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="ca-nstab-main" class="selected mw-list-item"><a href="/wiki/Tumor-infiltrating_lymphocytes" title="View the content page [c]" accesskey="c"><span>Article</span></a></li><li id="ca-talk" class="mw-list-item"><a href="/wiki/Talk:Tumor-infiltrating_lymphocytes" rel="discussion" title="Discuss improvements to the content page [t]" accesskey="t"><span>Talk</span></a></li></ul>
		
	</div>
</nav>

			
<nav id="p-variants" class="mw-portlet mw-portlet-variants emptyPortlet vector-menu-dropdown-noicon vector-menu vector-menu-dropdown" aria-labelledby="p-variants-label" role="navigation" 
	 >
	<input type="checkbox"
		id="p-variants-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-p-variants"
		class="vector-menu-checkbox" aria-labelledby="p-variants-label" />
	<label id="p-variants-label" aria-label="Change language variant" class="vector-menu-heading">
		<span class="vector-menu-heading-label">English</span>
	</label>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"></ul>
		
	</div>
</nav>

		</div>
		<div id="right-navigation">
			
<nav id="p-views" class="mw-portlet mw-portlet-views vector-menu vector-menu-tabs" aria-labelledby="p-views-label" role="navigation" 
	 >
	<label id="p-views-label" aria-label="" class="vector-menu-heading">
		<span class="vector-menu-heading-label">Views</span>
	</label>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="ca-view" class="selected mw-list-item"><a href="/wiki/Tumor-infiltrating_lymphocytes"><span>Read</span></a></li><li id="ca-edit" class="mw-list-item"><a href="/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;action=edit" title="Edit this page [e]" accesskey="e"><span>Edit</span></a></li><li id="ca-history" class="mw-list-item"><a href="/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;action=history" title="Past revisions of this page [h]" accesskey="h"><span>View history</span></a></li></ul>
		
	</div>
</nav>

			
<nav id="p-cactions" class="mw-portlet mw-portlet-cactions emptyPortlet vector-menu-dropdown-noicon vector-menu vector-menu-dropdown" aria-labelledby="p-cactions-label" role="navigation"  title="More options"
	 >
	<input type="checkbox"
		id="p-cactions-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-p-cactions"
		class="vector-menu-checkbox" aria-labelledby="p-cactions-label" />
	<label id="p-cactions-label" aria-label="" class="vector-menu-heading">
		<span class="vector-menu-heading-label">More</span>
	</label>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"></ul>
		
	</div>
</nav>

			
<div id="p-search" role="search" class="vector-search-box-vue  vector-search-box-show-thumbnail vector-search-box-auto-expand-width vector-search-box">
	<div>
			<h3 >
				<label for="searchInput">Search</label>
			</h3>
		<form action="/w/index.php" id="searchform"
			class="vector-search-box-form">
			<div id="simpleSearch"
				class="vector-search-box-inner"
				 data-search-loc="header-navigation">
				<input class="vector-search-box-input"
					 type="search" name="search" placeholder="Search Wikipedia" aria-label="Search Wikipedia" autocapitalize="sentences" title="Search Wikipedia [f]" accesskey="f" id="searchInput"
				/>
				<input type="hidden" name="title" value="Special:Search"/>
				<input id="mw-searchButton"
					 class="searchButton mw-fallbackSearchButton" type="submit" name="fulltext" title="Search Wikipedia for this text" value="Search" />
				<input id="searchButton"
					 class="searchButton" type="submit" name="go" title="Go to a page with this exact name if it exists" value="Go" />
			</div>
		</form>
	</div>
</div>

		</div>
	</div>
	

<div id="mw-panel">
	<div id="p-logo" role="banner">
		<a class="mw-wiki-logo" href="/wiki/Main_Page"
			title="Visit the main page"></a>
	</div>
	
<nav id="p-navigation" class="mw-portlet mw-portlet-navigation vector-menu vector-menu-portal portal" aria-labelledby="p-navigation-label" role="navigation" 
	 >
	<label id="p-navigation-label" aria-label="" class="vector-menu-heading">
		<span class="vector-menu-heading-label">Navigation</span>
	</label>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="n-mainpage-description" class="mw-list-item"><a href="/wiki/Main_Page" icon="home" title="Visit the main page [z]" accesskey="z"><span>Main page</span></a></li><li id="n-contents" class="mw-list-item"><a href="/wiki/Wikipedia:Contents" title="Guides to browsing Wikipedia"><span>Contents</span></a></li><li id="n-currentevents" class="mw-list-item"><a href="/wiki/Portal:Current_events" title="Articles related to current events"><span>Current events</span></a></li><li id="n-randompage" class="mw-list-item"><a href="/wiki/Special:Random" icon="die" title="Visit a randomly selected article [x]" accesskey="x"><span>Random article</span></a></li><li id="n-aboutsite" class="mw-list-item"><a href="/wiki/Wikipedia:About" title="Learn about Wikipedia and how it works"><span>About Wikipedia</span></a></li><li id="n-contactpage" class="mw-list-item"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia"><span>Contact us</span></a></li><li id="n-sitesupport" class="mw-list-item"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us by donating to the Wikimedia Foundation"><span>Donate</span></a></li></ul>
		
	</div>
</nav>

	
<nav id="p-interaction" class="mw-portlet mw-portlet-interaction vector-menu vector-menu-portal portal" aria-labelledby="p-interaction-label" role="navigation" 
	 >
	<label id="p-interaction-label" aria-label="" class="vector-menu-heading">
		<span class="vector-menu-heading-label">Contribute</span>
	</label>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="n-help" class="mw-list-item"><a href="/wiki/Help:Contents" icon="help" title="Guidance on how to use and edit Wikipedia"><span>Help</span></a></li><li id="n-introduction" class="mw-list-item"><a href="/wiki/Help:Introduction" title="Learn how to edit Wikipedia"><span>Learn to edit</span></a></li><li id="n-portal" class="mw-list-item"><a href="/wiki/Wikipedia:Community_portal" title="The hub for editors"><span>Community portal</span></a></li><li id="n-recentchanges" class="mw-list-item"><a href="/wiki/Special:RecentChanges" icon="recentChanges" title="A list of recent changes to Wikipedia [r]" accesskey="r"><span>Recent changes</span></a></li><li id="n-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Add images or other media for use on Wikipedia"><span>Upload file</span></a></li></ul>
		
	</div>
</nav>

<nav id="p-tb" class="mw-portlet mw-portlet-tb vector-menu vector-menu-portal portal" aria-labelledby="p-tb-label" role="navigation" 
	 >
	<label id="p-tb-label" aria-label="" class="vector-menu-heading">
		<span class="vector-menu-heading-label">Tools</span>
	</label>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="t-whatlinkshere" class="mw-list-item"><a href="/wiki/Special:WhatLinksHere/Tumor-infiltrating_lymphocytes" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j"><span>What links here</span></a></li><li id="t-recentchangeslinked" class="mw-list-item"><a href="/wiki/Special:RecentChangesLinked/Tumor-infiltrating_lymphocytes" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k"><span>Related changes</span></a></li><li id="t-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u"><span>Upload file</span></a></li><li id="t-specialpages" class="mw-list-item"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q"><span>Special pages</span></a></li><li id="t-permalink" class="mw-list-item"><a href="/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;oldid=1060517838" title="Permanent link to this revision of this page"><span>Permanent link</span></a></li><li id="t-info" class="mw-list-item"><a href="/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;action=info" title="More information about this page"><span>Page information</span></a></li><li id="t-cite" class="mw-list-item"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Tumor-infiltrating_lymphocytes&amp;id=1060517838&amp;wpFormIdentifier=titleform" title="Information on how to cite this page"><span>Cite this page</span></a></li><li id="t-wikibase" class="mw-list-item"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q7852668" title="Structured data on this page hosted by Wikidata [g]" accesskey="g"><span>Wikidata item</span></a></li></ul>
		
	</div>
</nav>

<nav id="p-coll-print_export" class="mw-portlet mw-portlet-coll-print_export vector-menu vector-menu-portal portal" aria-labelledby="p-coll-print_export-label" role="navigation" 
	 >
	<label id="p-coll-print_export-label" aria-label="" class="vector-menu-heading">
		<span class="vector-menu-heading-label">Print/export</span>
	</label>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="coll-download-as-rl" class="mw-list-item"><a href="/w/index.php?title=Special:DownloadAsPdf&amp;page=Tumor-infiltrating_lymphocytes&amp;action=show-download-screen" title="Download this page as a PDF file"><span>Download as PDF</span></a></li><li id="t-print" class="mw-list-item"><a href="/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;printable=yes" title="Printable version of this page [p]" accesskey="p"><span>Printable version</span></a></li></ul>
		
	</div>
</nav>

	
<nav id="p-lang" class="mw-portlet mw-portlet-lang vector-menu vector-menu-portal portal" aria-labelledby="p-lang-label" role="navigation" 
	 >
	<label id="p-lang-label" aria-label="" class="vector-menu-heading">
		<span class="vector-menu-heading-label">Languages</span>
	</label>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li class="interlanguage-link interwiki-ar mw-list-item"><a href="https://ar.wikipedia.org/wiki/%D9%84%D9%85%D9%81%D8%A7%D9%88%D9%8A%D8%A7%D8%AA_%D9%85%D8%B1%D8%AA%D8%B4%D8%AD%D8%A9_%D8%A8%D8%A7%D9%84%D9%88%D8%B1%D9%85" title="لمفاويات مرتشحة بالورم – Arabic" lang="ar" hreflang="ar" class="interlanguage-link-target"><span>العربية</span></a></li><li class="interlanguage-link interwiki-cs mw-list-item"><a href="https://cs.wikipedia.org/wiki/Lymfocyty_infiltruj%C3%ADc%C3%AD_n%C3%A1dory" title="Lymfocyty infiltrující nádory – Czech" lang="cs" hreflang="cs" class="interlanguage-link-target"><span>Čeština</span></a></li><li class="interlanguage-link interwiki-et mw-list-item"><a href="https://et.wikipedia.org/wiki/TIL-rakk" title="TIL-rakk – Estonian" lang="et" hreflang="et" class="interlanguage-link-target"><span>Eesti</span></a></li><li class="interlanguage-link interwiki-es mw-list-item"><a href="https://es.wikipedia.org/wiki/Linfocitos_infiltrantes_de_tumor" title="Linfocitos infiltrantes de tumor – Spanish" lang="es" hreflang="es" class="interlanguage-link-target"><span>Español</span></a></li><li class="interlanguage-link interwiki-it mw-list-item"><a href="https://it.wikipedia.org/wiki/Linfociti_infiltranti_il_tumore" title="Linfociti infiltranti il tumore – Italian" lang="it" hreflang="it" class="interlanguage-link-target"><span>Italiano</span></a></li><li class="interlanguage-link interwiki-tr mw-list-item"><a href="https://tr.wikipedia.org/wiki/T%C3%BCm%C3%B6r%C3%BC_infiltre_eden_lenfositler" title="Tümörü infiltre eden lenfositler – Turkish" lang="tr" hreflang="tr" class="interlanguage-link-target"><span>Türkçe</span></a></li><li class="interlanguage-link interwiki-zh mw-list-item"><a href="https://zh.wikipedia.org/wiki/%E8%82%BF%E7%98%A4%E6%B5%B8%E6%B6%A6%E6%B7%8B%E5%B7%B4%E7%BB%86%E8%83%9E" title="肿瘤浸润淋巴细胞 – Chinese" lang="zh" hreflang="zh" class="interlanguage-link-target"><span>中文</span></a></li></ul>
		<div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q7852668#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>
	</div>
</nav>

</div>

</div>

<footer id="footer" class="mw-footer" role="contentinfo" >
	<ul id="footer-info">
	<li id="footer-info-lastmod"> This page was last edited on 16 December 2021, at 01:06<span class="anonymous-show">&#160;(UTC)</span>.</li>
	<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License 3.0</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//foundation.wikimedia.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//foundation.wikimedia.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
</ul>

	<ul id="footer-places">
	<li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Privacy_policy" class="extiw" title="wmf:Privacy policy">Privacy policy</a></li>
	<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
	<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
	<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
	<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Tumor-infiltrating_lymphocytes&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
	<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
	<li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li>
	<li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Cookie_statement">Cookie statement</a></li>
</ul>

	<ul id="footer-icons" class="noprint">
	<li id="footer-copyrightico"><a href="https://wikimediafoundation.org/"><img src="/static/images/footer/wikimedia-button.png" srcset="/static/images/footer/wikimedia-button-1.5x.png 1.5x, /static/images/footer/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation" loading="lazy" /></a></li>
	<li id="footer-poweredbyico"><a href="https://www.mediawiki.org/"><img src="/static/images/footer/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/static/images/footer/poweredby_mediawiki_132x47.png 1.5x, /static/images/footer/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></li>
</ul>

</footer>

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.423","walltime":"0.459","ppvisitednodes":{"value":1692,"limit":1000000},"postexpandincludesize":{"value":94155,"limit":2097152},"templateargumentsize":{"value":818,"limit":2097152},"expansiondepth":{"value":8,"limit":100},"expensivefunctioncount":{"value":0,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":121031,"limit":5000000},"entityaccesscount":{"value":0,"limit":400},"timingprofile":["100.00%  354.968      1 -total","100.00%  354.968      1 Template:Reflist"," 74.37%  264.000     28 Template:Cite_journal","  1.52%    5.392      1 Template:Cite_news","  1.37%    4.849      1 Template:Cite_web","  1.03%    3.655      1 Template:Main_other","  0.48%    1.696      2 Template:ClinicalTrialsGov"]},"scribunto":{"limitreport-timeusage":{"value":"0.224","limit":"10.000"},"limitreport-memusage":{"value":4094097,"limit":52428800}},"cachereport":{"origin":"mw1435","timestamp":"20220323231705","ttl":1814400,"transientcontent":false}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Tumor-infiltrating lymphocytes","url":"https:\/\/en.wikipedia.org\/wiki\/Tumor-infiltrating_lymphocytes","sameAs":"http:\/\/www.wikidata.org\/entity\/Q7852668","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q7852668","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2007-12-06T02:36:00Z","dateModified":"2021-12-16T01:06:28Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/0\/04\/Tumor_microenvironment.jpg","headline":"lymphocyte that show specificity for autologous tumor cells"}</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":161,"wgHostname":"mw1332"});});</script>
</body>
</html>